4.03.2011
Please take five minutes...
brain repair after stroke
principles of brain repair from grand rounds
1. brain repair is time sensitive - stroke physiology is a sequence of cellular events, have to time treatments accordingly (sequence growth factors, or if give NMDA blockers early kill recovery)
2. brain repair is experience dependent - need exposure to the lost function, task specific rehabilitation + repitition that leads to increase in behavioral recovery
3. have to optimize patient selection type, many therapies are $$, and there are many variables that modify outcome (age, handedness, genetics, medications, timing of events...)
4.value of domain specific endpoints - less global endpoints may be needed to understand repair issues because global recovery may be too broad to measure whats working
4.02.2011
List of all neuro programs
American Academy of Neurology practice bulletin regarding prescription of "neuroenhancement" in well adults
practice of medicine traditional goals or obligations
1. prevent and diagnose disease or injury
2. cure/treat the disease or injury
3. reduce suffering
4. educate
5. help patients die in peace and dignity
6. reassure the well
ethically more complicated behaviors
1. participating in executions
2. participating in interrogations
i add these
3. use of medicine as a direct coercive force
4. research and experimentation with complicated ethical questions
5. profit motivated medicine
role is divided into
core domain
-these are obligatory
secondary domain
-considered ethically permissible
AAN describes prescribing medication for the purpose of neuroenhancement at best to fall into the category of secondary domain and at worst ethically impermissible
reasons prescribing for enhancement may be considered permissible
-improves well being (similarly to plastic surgery)
-benefits > risks
issues worth considering before prescribing-
-prescriptions will be "off-label" until medications are specifically designed and approved for the purpose of enhancement
-"off label" use should be based on
1. plausible rationale
2. based on available evidence
3. consistent w/standard of care (unfortunately very little clinical evidence to inform this use)
-before prescribing must inform patient
1. not FDA approved for this use
2. side effects
3. risks (short term and long term)
4. alternatives to not taking the medication
Ethical considerations before prescribing
-Thorough assessment of patient
e.g. - just because a patient is requesting neuroenhancement does not mean they are well, have to do a full work up for existing pathology. the request itself may be evidence of existing condition or the patient's interpretation of their symptoms
thus the request for neuroenhancement is still a "chief complaint"
-Beneficence and nonmaleficence
the putative benefits of enhancement (increased competitiveness, intelligence etc) are difficult to quantify and thus difficult to compare to the risks of treatment. thus clearly stating treatment goals will help the physician
-Distributive justice
drugs unlikely to be covered by third party payers, will remain in the domain of the rich, so consider the effects of limited access on society.
-conflict of interest
"avoid financial arrangements that influence patient care", inform patients of conflict of interest (stock, financial incentives etc...)
-Liability
courts will probably analyze injury claims for neuroenhancement similarly as they do other cosmetic procedures - courts may or may not be more aggressive
case: Zalazar v Vercimack - expert witness testimony is not needed to prove causation for cases involving informed consent elective medical procedures because "there is no medical issue that requires explanation for the jury".
refrain from guaranteeing an outcome
The following are a couple of selected key practice guidelines put forth by the AAN
1. prescriptions of meds for "neuroenhancement" are not legally obligatory, not prohibited and legally permissible in the US
2. prescriptions of meds for "neuroenhancment" are not ethically obligatory or prohibited and therefore are permissible
3. there is limited evidence of efficacy and safety info for these agents
4. liability is uncertain and may favor the plaintiff
5. refusal to prescribe is both ethically and legally permissible
6. informed consent applies for the prescription of "neuroenhancing" meds
7. ending prescriptions for "neuroenhancement" after they have been initiated is both legally and ethically permissible
Reference:
Larriviere D, Williams M, Rizzo M, Bonnie R. "Responding to requests from adult patients for neuroenhancments, Guidance of the Ethics, Law and Humanities Committee" 2009. American Academy of Neurology. www.neurology.org
4.01.2011
The macula speaks softly but carries a big stick.
ophtho notes last day
glaucoma (cannot be prevented, but goal is to prevent losing eyesight within their lifetime)
epi
2nd most common cause of blindness in world (cataract #1)
asymptomatic!! like htn
glaucoma - no longer just increased intraocular pressure, need nerve damage now for definition
look for donut hole in optic nerve
sensitivity of IOP w/pressure of >21mmHg is 50%!!!!
narrow angle
pressure lowering drug - acetazolamide, timolol
laser iridotomy - putting a hole in the iris to assist in aqueous flow
open angle treatment
-prostaglandins, beta blocker, alpha agonist.
-drainage shunts can be placed
exfoliative glaucoma is when the iris sheds cells and pigment (during pupillary constriction/dilation) and blockes aqueous outflow.
family history
sibling odds ration 3.7
parents odds ratio 2.2
nasal field defect can clue you in to glaucoma because very rare to find neurological cause of nasal field defect